Original Article

Diffuse Myelitis after Treatment of Cerebral Aspergillosis in an Immune Competent Patient

Abstract

Presentation of an unusual case of cerebral aspergillosis in an immune competent patient who was treated successfully but symptoms and signs of a demyelinating process following initial recovery has been occurred. A 29-year-old male with focal seizure. Brain MRI revealed small multiple hemispheric and dural lesions. An open biopsy was conducted. Histological evaluation revealed hyphe-like structure in the necrotic area, within vessel walls, and lumina, suggestive aspergillus fumigatus . Furthermore, brancheal hyphae in potassium hydrxide15% and colonies on sabourud dextrose agar were observed. Based of the above findings the patient underwent anti fungal therapy. The patient recovered and continued a normal life however a follow up MRI was performed after 3 months from recovery. No significant abnormality was observed from the MRI procedure. One month later the patient developed signs and symptoms of spinal cord involvement which seemed to be the result of myelitis. A brain MR showed no abnormalities .Therefore it seemed reasonable to administer corticosteroid as a treatment for suspected active demyelinating process. During the above treatment, signs and symptoms of myelopathy disappeared and a whole spine MRI showed remarkable improvement.

Cortet B, Richard R, Deprez X, Lucet L, Flipo RM, Le Loët X, Duquesnoy B, Delcambre B. Aspergillus spondylodiscitis: successful conservative treatment in 9 cases. J Rheumatol 1994;21(7):1287-91.

Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985;18(5):574-82.

Lucchinetti C, Brück W, Parisi J, Scheithauer B,Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000;47(6):707-17.

Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Weinshenker BG,Rodriguez M. Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology 2004;62(1):51-9.

Khoo TK, Sugai K, Leong TK. Disseminated aspergillosis. Case report and review of the world literature. Am J ClinPathol 1966;45(6):697-703.

Siddiqui AA, Shah AA, Bashir SH. Craniocerebral aspergillosis of sinonasal origin in immunocompetent patients: clinical spectrum and outcome in 25 cases.Neurosurgery 2004;55(3):602-11; discussion 611-3.

Hall WA. Neurosurgical infections in the compromised host. Neurosurg Clin N Am 1992;3(2):435-42.

Saravia-Gomez J. Aspergillosis of the central nervoussystem. In: Vinken PJ, Bruyn GW, editors, Handbook of Clinical Neurology. Holland: North-Holland Publishing Company; 1978. p. 395-400.

Seres JL, Ono H, Benner EJ. Aspergillosis presenting as spinal cord compression. Case report. J Neurosurg 1972;36(2):221-4.

Craner MJ, Newcombe J, Black JA, Hartle C, Cuzner ML, Waxman SG. Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6sodium channels and Na+/Ca2+ exchanger. Proc Natl Acad Sci U S A 2004;101(21):8168-73. Epub 2004 May 17.

McDonald WI. Mechanisms of functional loss and recovery in spinal cord damage. Ciba Found Symp 1975;(34):23-33.

Macgregor JD, MacDonald J, Ingram EA, McDonnell M, Marshall B. Epidemic measles in Shetland during 1977 and 1978. Br Med J (Clin Res Ed) 1981;282(6262):434-6.

Files
IssueVol 49, No 6 (2011) QRcode
SectionOriginal Article(s)
Keywords
Aspergillus fumigates Aspergillosis Myelitis

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Mollahoseini R, Nikoobakht M. Diffuse Myelitis after Treatment of Cerebral Aspergillosis in an Immune Competent Patient. Acta Med Iran. 1;49(6):402-406.